Get a Comprehensive Insight into the Pharmaceutical Market in India

DUBLIN, Ireland--(Business Wire)--
Research and Markets
(http://www.researchandmarkets.com/reports/c88270) has announced the
addition of "IMS World Review Country Profile - India" to their
offering.

IMS Health's Country Profiles provide a comprehensive insight into
the national sales of the pharmaceutical market in selected countries
over 5 years. Each individual IMS Company Profile analyzes the
critical components that make up a pharmaceutical company, providing
you with a clear assessment of the relative strengths and weaknesses
of a company's business strategy. Sales performance is analysed in
terms of geographic region, major corporations, therapeutic classes,
major products and new product activity.

All data is available over a 5 year period for easy trend analysis
and is based on Quarter 4 sales figures.

Country Profiles are available for:

Argentina, Australia, Austria, Belgium, Brazil, Canada, China,
Czech Republic, Egypt, Finland, France, Germany, India, Indonesia,
Italy, Mexico, Netherlands, Poland, Portugal, Russian Federation,
South Africa, South Korea, Spain, Switzerland, Taiwan, Turkey, United
Kingdom and United States.

-0-
*T
Products Mentioned:

Augmentin
Becosules
Combiflam
Corex
Human Mixtard30/70
Monocef
Nise
Phensedyl Cough
Rabipur
Voveran

Companies Mentioned:

-Glaxosmithkline
-Cipla
-Sun Pharma
-Dr Reddys Labs
-Aventis Pharma
-Alkem
-Lupin Labs
-Nicholas Piramal
-Ranbaxy
-Zydus Cadila
-Abbott
-Aristo Pharma
-Torrent Pharma
-Novartis
-Mankind
-Pfizer
-Micro Labs
-Fdc
-U S V
-Intas
-Alembic
-Wockhardt
-Ipca Labs
-German Remedies
-Glenmark Pharma
-Macleods Pharma
-Rhone Poulenc
-Merck Limited
-Wyeth Limited
-Elder Pharma
-Astrazeneca
-Cadila Pharma
-Unichem
-Emcure
-Dabur
*T

For more information, visit
here

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
Fax: +353 1 4100 980

Copyright Business Wire 2008